Given the heterogeneity of PCOS phenotypes, understanding whether vasorin levels correlate with specific clinical subgroups may aid in refining diagnostic algorithms and identifying potential therapeutic targets. This evidence concerns the gene VASN and polycystic ovary syndrome.